BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gavriilaki E, Asteris PG, Touloumenidou T, Koravou EE, Koutra M, Papayanni PG, Karali V, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Grigoriadis S, Rapti E, Chloros D, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Sakellari I, Kalantzis IG, Parastatidis ST, Koopialipoor M, Cavaleri L, Armaghani DJ, Papadopoulou A, Brodsky RA, Kokoris S, Anagnostopoulos A. Genetic justification of severe COVID-19 using a rigorous algorithm. Clin Immunol 2021;226:108726. [PMID: 33845193 DOI: 10.1016/j.clim.2021.108726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Reference Citation Analysis]
3 Zeng J, Roussis PC, Mohammed AS, Maraveas C, Fatemi SA, Armaghani DJ, Asteris PG. Prediction of Peak Particle Velocity Caused by Blasting through the Combinations of Boosted-CHAID and SVM Models with Various Kernels. Applied Sciences 2021;11:3705. [DOI: 10.3390/app11083705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
4 Kumar G, Nanchal R, Hererra M, Sakhuja A, Patel D, Meersman M, Dalton D, Guddati AK. Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients? J Hematol 2021;10:98-105. [PMID: 34267846 DOI: 10.14740/jh824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 El Sissy C, Saldman A, Zanetta G, Martins PV, Poulain C, Cauchois R, Kaplanski G, Venetz JP, Bobot M, Dobosziewicz H, Daniel L, Koubi M, Sadallah S, Rotman S, Mousson C, Pascual M, Frémeaux-Bacchi V, Fakhouri F. COVID-19 as a potential trigger of complement-mediated atypical HUS. Blood 2021;138:1777-82. [PMID: 34482396 DOI: 10.1182/blood.2021012752] [Reference Citation Analysis]
6 Higashikuni Y, Liu W, Obana T, Sata M. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications. Int J Mol Sci 2021;22:12081. [PMID: 34769508 DOI: 10.3390/ijms222112081] [Reference Citation Analysis]
7 Gavriilaki E, Dalampira D, Theodorakakou F, Liacos CI, Kanellias N, Eleutherakis-Papaiakovou E, Terpos E, Gavriatopoulou M, Verrou E, Triantafyllou T, Sevastoudi A, Koravou EE, Touloumenidou T, Varelas C, Papalexandri A, Sakellari I, Dimopoulos MA, Kastritis E, Katodritou E. Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls. J Clin Med 2022;11:3355. [PMID: 35743426 DOI: 10.3390/jcm11123355] [Reference Citation Analysis]
8 Asteris PG, Gavriilaki E, Touloumenidou T, Koravou E, Koutra M, Papayanni PG, Pouleres A, Karali V, Lemonis ME, Mamou A, Skentou AD, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Rapti E, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Papadopoulou A, Kalantzis IG, Vallianatou LA, Armaghani DJ, Cavaleri L, Gandomi AH, Hajihassani M, Hasanipanah M, Koopialipoor M, Lourenço PB, Samui P, Zhou J, Sakellari I, Valsami S, Politou M, Kokoris S, Anagnostopoulos A. Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship. Thrombosis Update 2021;5:100062. [DOI: 10.1016/j.tru.2021.100062] [Reference Citation Analysis]
10 Mohammed AS, Asteris PG, Koopialipoor M, Alexakis DE, Lemonis ME, Armaghani DJ. Stacking Ensemble Tree Models to Predict Energy Performance in Residential Buildings. Sustainability 2021;13:8298. [DOI: 10.3390/su13158298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Jamaly S, Tsokos MG, Bhargava R, Brook OR, Hecht JL, Abdi R, Moulton VR, Satyam A, Tsokos GC. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021;229:108795. [PMID: 34252574 DOI: 10.1016/j.clim.2021.108795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Buonsenso D, Gennaro LD, Rose C, Morello R, D'Ilario F, Zampino G, Piazza M, Boner AL, Iraci C, O'Connell S, Cohen VB, Esposito S, Munblit D, Reena J, Sigfrid L, Valentini P. Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid. Future Microbiol 2022. [PMID: 35264003 DOI: 10.2217/fmb-2022-0031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. Journal of Laboratory Medicine 2021;45:293-302. [DOI: 10.1515/labmed-2021-0134] [Reference Citation Analysis]
14 Henry BM, Sinkovits G, Szergyuk I, de Oliveira MHS, Lippi G, Benoit JL, Favaloro EJ, Pode-shakked N, Benoit SW, Cooper DS, Müller V, Iványi Z, Gál J, Réti M, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Mező B, Kiszel P, Masszi T, Vályi-nagy I, Prohászka Z. Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study. Front Med 2022;9:796109. [DOI: 10.3389/fmed.2022.796109] [Reference Citation Analysis]